These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8662825)

  • 21. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
    Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.
    Blain SW; Montalvo E; Massagué J
    J Biol Chem; 1997 Oct; 272(41):25863-72. PubMed ID: 9325318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins.
    Karaiskou A; Perez LH; Ferby I; Ozon R; Jessus C; Nebreda AR
    J Biol Chem; 2001 Sep; 276(38):36028-34. PubMed ID: 11461916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The protein SET regulates the inhibitory effect of p21(Cip1) on cyclin E-cyclin-dependent kinase 2 activity.
    Estanyol JM; Jaumot M; Casanovas O; Rodriguez-Vilarrupla A; Agell N; Bachs O
    J Biol Chem; 1999 Nov; 274(46):33161-5. PubMed ID: 10551888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells.
    Pan MH; Chen WJ; Lin-Shiau SY; Ho CT; Lin JK
    Carcinogenesis; 2002 Oct; 23(10):1677-84. PubMed ID: 12376477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
    Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities.
    He G; Siddik ZH; Huang Z; Wang R; Koomen J; Kobayashi R; Khokhar AR; Kuang J
    Oncogene; 2005 Apr; 24(18):2929-43. PubMed ID: 15735718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.
    Choi YH; Lee WH; Park KY; Zhang L
    Jpn J Cancer Res; 2000 Feb; 91(2):164-73. PubMed ID: 10761703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
    Upton JW; van Dyk LF; Speck SH
    Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
    Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
    Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity.
    Calbó J; Serna C; Garriga J; Graña X; Mazo A
    Cell Death Differ; 2004 Oct; 11(10):1055-65. PubMed ID: 15309028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
    Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
    Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells.
    Ishida A; Sasaguri T; Kosaka C; Nojima H; Ogata J
    J Biol Chem; 1997 Apr; 272(15):10050-7. PubMed ID: 9092548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
    Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation.
    Terada Y; Tatsuka M; Jinno S; Okayama H
    Nature; 1995 Jul; 376(6538):358-62. PubMed ID: 7630405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dna damage-induced G(1) arrest in hematopoietic cells is overridden following phosphatidylinositol 3-kinase-dependent activation of cyclin-dependent kinase 2.
    Eapen AK; Henry MK; Quelle DE; Quelle FW
    Mol Cell Biol; 2001 Sep; 21(18):6113-21. PubMed ID: 11509654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages.
    Matsuoka M; Tani K; Asano S
    Oncogene; 1998 Apr; 16(16):2075-86. PubMed ID: 9572488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.